| Patents for A61P 17 - Drugs for dermatological disorders (106,455) |
|---|
| 07/26/2000 | CN1054856C New 19-nor steroids having phenoxyalkylsulphonemide or phenoxyalkylsulphonylurea chain in position llbeta, preparation process and intermediates, use as medicaments and pharmaceutical |
| 07/26/2000 | CN1054774C Specific effect liquid medicine for treating burn or scald |
| 07/26/2000 | CN1054769C Chinese medicinal preparation for treatment of psoriasis and preparation method thereof |
| 07/26/2000 | CN1054767C Pharmaceutical preparation for treatment of leukoderma |
| 07/26/2000 | CN1054748C Medicine for acne |
| 07/26/2000 | CA2296965A1 Use of bacterium for manufacture of a vaccine |
| 07/25/2000 | US6093838 Amines substituted with a dihydro-benzofuranyl or with a dihydro-isobenzofuranyl group, an aryl or heteroaryl group and an alkyl group, having retinoid-like biological activity |
| 07/25/2000 | US6093828 Form of (E)-3-[6-[[(2,6-dichlorophenyl)-thio]methyl]-3-(2-phenylethoxy)-2-pyridi nyl]-2-propenoic acid |
| 07/25/2000 | US6093743 Therapeutic methods employing disulfide derivatives of dithiocarbamates and compositions useful therefor |
| 07/25/2000 | US6093740 Therapeutic treatment for skin disorders |
| 07/25/2000 | US6093730 Substituted isoquinoline-3-carboxamides, their preparation and their use as pharmaceuticals |
| 07/25/2000 | US6093696 N-acetyl-d-thioproline-(o-2,6-dichlorobenzyl)-l-tyrosine, for example; selectively inhibit the alpha 4 subgroup of integrins from binding to their ligands; use in prophylaxis or treatment of immune or inflammatory diseases |
| 07/25/2000 | US6093385 For protecting the human skin or human hair from the sun's rays |
| 07/20/2000 | WO2000042213A1 A novel method for designing protein kinase inhibitors |
| 07/20/2000 | WO2000042211A1 Methods of screening protease inhibitors, of inducing mice susceptible to hiv protease inhibitor-induced dyslipidemia, and genes associated therewith |
| 07/20/2000 | WO2000042071A2 Compounds and methods to inhibit or augment an inflammatory response |
| 07/20/2000 | WO2000042054A1 2,3-o-isopropylidene derivatives of monosaccharides as cell adhesion inhibitors |
| 07/20/2000 | WO2000042053A1 Derivatives of monosaccharides as cell adhesion inhibitors |
| 07/20/2000 | WO2000042031A2 Substituted 2-arylimino heterocycles and compositions containing them, for use as progesterone receptor binding agents |
| 07/20/2000 | WO2000042029A1 1-heterocycle substituted diarylamines |
| 07/20/2000 | WO2000042022A1 Benzoheterocycles and their use as mek inhibitors |
| 07/20/2000 | WO2000042020A1 Phenylphenanthridines with pde-iv inhibiting activity |
| 07/20/2000 | WO2000042019A1 6-arylphenanthridines with pde-iv inhibiting activity |
| 07/20/2000 | WO2000042018A1 Polysubstituted 6-phenylphenanthridines with pde-iv inhibiting activity |
| 07/20/2000 | WO2000042003A1 Benzenesulfonamide derivatives and their use as mek inhibitors |
| 07/20/2000 | WO2000042002A1 Sulphohydroxamic acids and sulphohydroxamates and their use as mek inhibitors |
| 07/20/2000 | WO2000041994A1 4-arylamino, 4-aryloxy, and 4-arylthio diarylamines and derivatives thereof as selective mek inhibitors |
| 07/20/2000 | WO2000041724A1 Modulation of systemic memory t cell trafficking |
| 07/20/2000 | WO2000041705A1 Pre-conditioning against cell death |
| 07/20/2000 | WO2000041691A1 Dry skin remedies |
| 07/20/2000 | WO2000041675A1 Cosmetics and skin preparations for external use |
| 07/20/2000 | WO2000041674A1 Use of a plant extract of the genus rosmarinus in compositions for treating ageing skin symptoms |
| 07/20/2000 | WO2000041669A2 Benzimidazole vascular damaging agents |
| 07/20/2000 | WO2000041566A1 Regulation of endogenous gene expression in cells using zinc finger proteins |
| 07/20/2000 | WO2000041548A2 Methods for glucagon suppression |
| 07/20/2000 | WO2000041545A2 Regulators of the pct or smoothened pathway, compositions and uses related thereto |
| 07/20/2000 | WO2000041505A2 Anthranilic acid derivatives |
| 07/20/2000 | WO2000014097A3 Novel pyranoses |
| 07/20/2000 | WO2000013649A3 Use of lithium gluconate for making a medicine for treating herpes and seborrheic dermatitis |
| 07/20/2000 | CA2697598A1 Compounds and methods to inhibit or augment an inflammatory response |
| 07/20/2000 | CA2370042A1 Regulators of the pct or smoothened pathway, compositions and uses related thereto |
| 07/20/2000 | CA2360581A1 A novel method for designing protein kinase inhibitors |
| 07/20/2000 | CA2360488A1 Use of a plant extract of the genus rosmarinus in compositions for treating ageing skin symptoms |
| 07/20/2000 | CA2360386A1 Polysubstituted 6-phenylphenanthridines with pde-iv inhibiting activity |
| 07/20/2000 | CA2360268A1 Pre-conditioning against cell death |
| 07/20/2000 | CA2359986A1 2,3-o-isopropylidene derivatives of monosaccharides as cell adhesion inhibitors |
| 07/20/2000 | CA2359980A1 Derivatives of monosaccharides as cell adhesion inhibitors |
| 07/20/2000 | CA2359798A1 Methods of screening protease inhibitors, of inducing mice susceptible to hiv protease inhibitor-induced dyslipidemia, and genes associated therewith |
| 07/20/2000 | CA2359562A1 Substituted 2-arylimino heterocycles and compositions containing them, for use as progesterone receptor binding agents |
| 07/20/2000 | CA2359416A1 6-arylphenanthridines with pde-iv inhibiting activity |
| 07/20/2000 | CA2356939A1 Modulation of systemic memory t cell trafficking |
| 07/20/2000 | CA2356850A1 Dry skin remedies |
| 07/20/2000 | CA2355374A1 1-heterocycle substituted diarylamines |
| 07/20/2000 | CA2349832A1 Benzenesulfonamide derivatives and their use as mek inhibitors |
| 07/20/2000 | CA2349467A1 Sulphohydroxamic acids and sulphohydroxamates and their use as mek inhibitors |
| 07/20/2000 | CA2349180A1 Anthranilic acid derivatives |
| 07/20/2000 | CA2348236A1 4-arylamino, 4-aryloxy, and 4-arylthio diarylamines and derivatives thereof as selective mek inhibitors |
| 07/19/2000 | EP1020461A2 Use of alkaline salts of the (-)-enantiomer of omeprazole |
| 07/19/2000 | EP1020460A2 The sodium salt of the (-)-enantiomer of omeprazole |
| 07/19/2000 | EP1020219A1 Nanoemulsion based on alkylether citrates and uses thereof in the fields of cosmetics, dermatology, pharmaceuticals and/or ophthalmology |
| 07/19/2000 | EP1020192A2 Composition against cellulitis |
| 07/19/2000 | EP1019514A1 A keratinocyte derived protease |
| 07/19/2000 | EP1019409A1 Poly(adp-ribose) polymerase ("parp") inhibitors, methods and pharmaceutical compositions for treating neural or cardiovascular tissue damage |
| 07/19/2000 | EP1019406A1 Pyrrolopyrrolone derivatives as inhibitors of neutrophil elastase |
| 07/19/2000 | EP1019396A1 Novel cycloalkyl substituted imidazoles |
| 07/19/2000 | EP1019394A1 PYRAZOLE DERIVATIVES AS p38 KINASE INHIBITORS |
| 07/19/2000 | EP1019360A1 $g(b)2-ADRENERGIC RECEPTOR AGONISTS |
| 07/19/2000 | EP1019091A1 50 human secreted proteins |
| 07/19/2000 | EP1019075A1 $g(b)2-ADRENERGIC RECEPTOR AGONISTS |
| 07/19/2000 | EP1019063A1 Modulation of immune responses |
| 07/19/2000 | EP1019059A1 USE OF FXR, PPARalpha AND LXRalpha ACTIVATORS TO RESTORE BARRIER FUNCTION, PROMOTE EPIDERMAL DIFFERENTIATION AND INHIBIT PROLIFERATION |
| 07/19/2000 | EP1019054A1 Treatment of skin disorders |
| 07/19/2000 | EP1019051A1 Peripherally acting anti-pruritic opiates |
| 07/19/2000 | EP1019040A1 INHIBITION OF p38 KINASE ACTIVITY BY ARYL UREAS |
| 07/19/2000 | EP1019036A1 Use of d-methionine to reduce the toxicity of ototoxic drugs, noise, and radiation |
| 07/19/2000 | EP1019034A2 Antioxidant enhancement of therapy for hyperproliferative conditions |
| 07/19/2000 | EP1019018A1 Mild, rinse-off antimicrobial liquid cleansing compositions |
| 07/19/2000 | EP1019006A1 Apparatus for the application of ozone/oxygen for the treatment of external pathogenic conditions |
| 07/19/2000 | EP1018896A1 Nutritional composition for the treatment of pressure ulcers |
| 07/19/2000 | EP0760819B1 Tricyclic dicarbonyl derivatives |
| 07/19/2000 | CN1260835A Truncated vegf-related proteins |
| 07/19/2000 | CN1260784A Quinoline derivatives as PDEIV and INF inhibitors |
| 07/19/2000 | CN1260707A Personal care compositions comprising adhesive copolymer |
| 07/19/2000 | CN1260706A Personal care composition comprising silicone-containing adhesive copolymer |
| 07/19/2000 | CN1260208A Medicine for dispelling imflammation |
| 07/19/2000 | CN1260192A Preparation method of external-application medicine for snake-bitten injury |
| 07/19/2000 | CN1260185A Dongchuangjin (wiping out frostbite) and its preparation technology |
| 07/19/2000 | CN1260184A Oral preparation of traditional Chinese medicine medicated composition for treating psoriasis and its preparation method |
| 07/19/2000 | CN1260170A Seabuckthorn essence concentrate |
| 07/19/2000 | CN1260169A Wash for stopping baldness, growing hair, blackening hair and relieving itching |
| 07/19/2000 | CN1260166A Water-in-oil emulsion type composition containing high-content vinegar and use in beauty and dermatology fields |
| 07/19/2000 | CN1054601C Fluoride like vitamine D3, its preparation method and use, and medicinal composition containing same |
| 07/19/2000 | CN1054538C Liniment for treating vitiligo and its preparing method |
| 07/19/2000 | CN1054528C Preparatory Chinese medicine for treating psoriasis |
| 07/18/2000 | US6090944 Alkanoic acid derivatives as αv integrin receptor antagonists |
| 07/18/2000 | US6090852 Matrix metalloprotease inhibitor |
| 07/18/2000 | US6090840 Peptidyl compounds having MMP and TNF inhibitory activity |
| 07/18/2000 | US6090826 Disubstituted acetylenes bearing heterobicyclic groups and heteroaromatic or phenyl groups having retinoid like activity |
| 07/18/2000 | US6090825 Oxazole derivatives as antagonists of alpha 1C andrenergic receptors |
| 07/18/2000 | US6090811 Analgesic |